Long Focus Capital Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.4M | Sell |
720,000
-9,504
| -1% | -$507K | 1.45% | 8 |
|
|
2025
Q1 | $29.5M | Buy |
729,504
+9,900
| +1% | +$401K | 0.99% | 16 |
|
|
2024
Q4 | $20M | Hold |
719,604
| – | – | 0.65% | 22 |
|
|
2024
Q3 | $20.6M | Hold |
719,604
| – | – | 0.72% | 18 |
|
|
2024
Q2 | $16.9M | Buy |
719,604
+391,000
| +119% | +$9.17M | 0.65% | 19 |
|
|
2024
Q1 | $8.3M | Sell |
328,604
-181,396
| -36% | -$4.58M | 0.42% | 40 |
|
|
2023
Q4 | $11.9M | Buy |
510,000
+366,000
| +254% | +$8.55M | 0.4% | 22 |
|
|
2023
Q3 | $7.28M | Hold |
144,000
| – | – | 0.26% | 36 |
|
|
2023
Q2 | $6.72M | Sell |
144,000
-20,000
| -12% | -$934K | 0.31% | 40 |
|
|
2023
Q1 | $6.27M | Hold |
164,000
| – | – | 0.36% | 36 |
|
|
2022
Q4 | $8.99M | Sell |
164,000
-128,000
| -44% | -$7.01M | 0.62% | 27 |
|
|
2022
Q3 | $9.94M | Buy |
292,000
+2,000
| +0.7% | +$68.1K | 0.97% | 11 |
|
|
2022
Q2 | $2.74M | Buy |
+290,000
| New | +$2.74M | 0.29% | 50 |
|